Literature DB >> 16573846

Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.

Mikko J Nyman1, Olli Eskola, Jaana Kajander, Tero Vahlberg, Sandra Sanabria, Donald Burns, Richard Hargreaves, Olof Solin, Jarmo Hietala.   

Abstract

Substance P (SP) is a neurotransmitter and neuromodulator that mediates its effects in the brain predominantly via the neurokinin-1 receptors (NK1Rs). NK1Rs and SP have been shown clinically to be involved in nausea and emesis after chemotherapy (CINV) and have been implicated preclinically in a range of neuropsychiatric disorders but unlike CINV their blockade in these conditions does not have proven clinical value. We investigated whether age and gender affects NK1R binding potential (NK1R-BP; an index of receptor availability) in the living human brain using PET and [18F]SPA-RQ, a highly specific NK1R antagonist. Forty-five healthy volunteers (35 male and 10 female), aged between 19 and 55 years were studied. NK1R-BP was estimated using the simplified reference tissue model with cerebellum as a reference region. A regression analysis indicated that that a loss of NK1R is associated with normal ageing as shown by decreased NK1R-BP (average rate 7% per decade). Statistically significant negative associations between age and NK1R-BP were observed in temporal, parietal and frontal cortex, hippocampus and parahippocampal formation. In addition preliminary data were obtained suggesting possible gender differences in NK1R-BP in the cortex and putamen with females having a lower NK1R-BP. The exact physiological significance of these results remains to be elucidated but conceptually they could be involved in age-related CNS disorders or those with gender differences in prevalence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573846     DOI: 10.1017/S1461145706006572

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  15 in total

1.  PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.

Authors:  Fumihiko Yasuno; Sandra M Sanabria; Donald Burns; Richard J Hargreaves; Subroto Ghose; Masanori Ichise; Frederick T Chin; Cheryl L Morse; Victor W Pike; Robert B Innis
Journal:  Synapse       Date:  2007-04       Impact factor: 2.562

2.  Age Differences in the Time Course and Magnitude of Changes in Circulating Neuropeptides After Pain Evocation in Humans.

Authors:  Joseph L Riley; Yenisel Cruz-Almeida; Margarete C Dasilva Ribeiro; Corey B Simon; Nathan R Eckert; Maria Aguirre; Heather L Sorenson; Patrick J Tighe; Robert R Edwards; Shannon M Wallet
Journal:  J Pain       Date:  2017-04-29       Impact factor: 5.820

3.  Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain.

Authors:  Johanna M Jarcho; Natasha A Feier; Alberto Bert; Jennifer A Labus; Maunoo Lee; Jean Stains; Bahar Ebrat; Stephanie M Groman; Kirsten Tillisch; Arthur L Brody; Edythe D London; Mark A Mandelkern; Emeran A Mayer
Journal:  Pain       Date:  2013-03-05       Impact factor: 6.961

4.  Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.

Authors:  A Frick; F Åhs; Å M Palmquist; A Pissiota; U Wallenquist; M Fernandez; M Jonasson; L Appel; Ö Frans; M Lubberink; T Furmark; L von Knorring; M Fredrikson
Journal:  Mol Psychiatry       Date:  2015-12-01       Impact factor: 15.992

5.  Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question.

Authors:  Richard E Kast
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

6.  Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.

Authors:  Jian-Ping Lai; Avital Cnaan; Huaqing Zhao; Steven D Douglas
Journal:  J Neurosci Methods       Date:  2007-10-17       Impact factor: 2.390

Review 7.  Sex and the migraine brain.

Authors:  D Borsook; N Erpelding; A Lebel; C Linnman; R Veggeberg; P E Grant; C Buettner; L Becerra; R Burstein
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

8.  Netupitant PET imaging and ADME studies in humans.

Authors:  Tulla Spinelli; Selma Calcagnile; Claudio Giuliano; Giorgia Rossi; Corinna Lanzarotti; Stuart Mair; Lloyd Stevens; Ian Nisbet
Journal:  J Clin Pharmacol       Date:  2013-11-08       Impact factor: 3.126

9.  Voxel-based NK1 receptor occupancy measurements with [(18)F]SPA-RQ and positron emission tomography: a procedure for assessing errors from image reconstruction and physiological modeling.

Authors:  Esa Wallius; Mikko Nyman; Vesa Oikonen; Jarmo Hietala; Ulla Ruotsalainen
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.484

10.  First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in man.

Authors:  Saskia P A Wolfensberger; Bart N M van Berckel; Anu J Airaksinen; Kaoru Maruyama; Mark Lubberink; Ronald Boellaard; William D H Carey; Wieb Reddingius; Dick J Veltman; Albert D Windhorst; Josée E Leysen; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2009-03-31       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.